Mind the costs, too: towards better cost-effectiveness analyses of PBF programmes.

Y-Ling Chi; Mohamed Gad ORCID logo; Sebastian Bauhoff; Kalipso Chalkidou; Itamar Megiddo; Francis Ruiz ORCID logo; Peter Smith; (2018) Mind the costs, too: towards better cost-effectiveness analyses of PBF programmes. BMJ GLOBAL HEALTH, 3 (5). e000994. ISSN 2059-7908 DOI: 10.1136/bmjgh-2018-000994
Copy

Summary box

- The evidence surrounding the cost-effectiveness of performance-based financing (PBF) is weak, and it is not clear how PBF compares with alternative interventions in terms of its value for money.

- It is important to fill this evidence gap as countries transition from aid and face increasing budget constraints and competing priorities for the use of their domestic resources.

- In conducting cost-effectiveness analyses of PBF, researchers should be mindful of the identification, measurement and valuation of costs and effects, provide justification for the scope of their studies, and specify appropriate comparators and decision rules.

- We also recommend the use of a reference case to lay out the principles, preferred methodological choices and reporting standards, as well as a checklist.


picture_as_pdf
Chi-etal-2018-mind-the-costs-too.pdf
subject
Published Version
Available under Creative Commons: 4.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads